头颈癌患者复发恐惧的危险因素
这项探索性研究于2017年对101例无病头颈癌幸存者进行横断面调查,使用复发恐惧问卷评估,并让患者选择随访方案。结果显示36.6%的患者存在复发恐惧升高,女性、≤65岁及有复发或第二原发恶性肿瘤史者复发恐惧更高。
要点
- 36.6%的无病头颈癌幸存者存在复发恐惧升高。
- 女性较男性、≤65岁较>65岁者的复发恐惧总体评分显著更高。
- 有复发或第二原发恶性肿瘤史者复发恐惧升高的相对风险增加。
核心结论
- 头颈癌患者的复发恐惧与女性、较年轻年龄以及既往复发或第二原发恶性肿瘤史相关。
- 由于复发恐惧患病率高,应在临床实践和未来研究中加以关注。
研究设计与样本
- 探索性研究,2017年对101例无病头颈癌幸存者进行横断面调查,调查包含复发恐惧问卷,随访时间点随机。
- 同时要求患者在四种随访方案中选择偏好方案,方案在是否系统影像检查及就诊频率上不同。
主要发现
- 36.6%的患者存在复发恐惧升高。
- 女性复发恐惧总体评分显著高于男性(评分差3.40;CI 0.49-6.32;p=0.022)。
- ≤65岁患者复发恐惧总体评分显著高于>65岁患者(评分差4.25;CI 1.58-6.92;p=0.002)。
- 有癌症复发或第二原发恶性肿瘤史者复发恐惧升高的相对风险增加(RR 1.7;CI 1.01-2.86;p=0.046)。
- 肿瘤分期和治疗方式与复发恐惧升高或复发恐惧总体评分无显著关联。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Fear of recurrence (FoR) affects the quality of life of head and neck cancer survivors. Identification of factors predisposing to FoR may help to recognize and treat patients at risk. MATERIALS AND METHODS: For this exploratory study, 101 disease-free head and neck cancer survivors completed a cross-sectional survey in 2017 that included the FoR questionnaire at a random point in time during their follow-up. Additionally, the patients were asked to choose their favorite among four follow-up schedules with or without systematic imaging and varying frequency of visits. RESULTS: Elevated FoR was present in 36.6% of patients. Females and patients ≤65 years showed significantly higher FoR overall scores than males (score difference 3.40; CI 0.49-6.32; p = 0.022) and patients >65 years (score difference 4.25; CI 1.58-6.92; p = 0.002). A history of cancer recurrence or second primary malignancy increased the relative risk (RR) for elevated FoR (RR 1.7; CI 1.01-2.86; p = 0.046). Tumor stage and treatment modality were not significantly associated with elevated FoR or FoR overall score. Higher FoR overall scores were recorded in patients who favored intensive follow-up plans (mean overall FoR score 18 vs. 15; SD 7.7; p = 0.076) and systematic imaging in follow-up (17 vs. 13, SD 7.1; p = 0.034). CONCLUSION: Fear of recurrence in head and neck cancer patients is associated with female sex, younger age, and history of a past recurrence or second primary malignancy. Due to its high prevalence, it should be addressed in clinical practice and future research. LEVEL OF EVIDENCE: NA Laryngoscope, 133:1630-1637, 2023.
引用
- Riggauer J, Blaser D, Elicin O, et al. Risk Factors for Fear of Recurrence in Head and Neck Cancer Patients. Laryngoscope. 2022. PMID: 36054694. doi:10.1002/lary.30340
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。